Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy

Nephrology Dialysis Transplantation

Volumn 11, Issue 6, 1996, Pages 1019-1023

  Tarnow, Lise ^a   Cambien, François ^b   Rossing, Peter ^a   Nielsen, Flemming S ^a   Hansen, Birgitte V ^a   Ricard, Sylvain ^b   Poirier, Odette ^b   Parving, Hans Henrik ^a  

^a STENO DIABETES CENTER   (Denmark)

^b INSERM   (France)

Author keywords

Angiotensin II type 1 receptor gene polymorphism; Diabetic nephropathy; IDDM; Proliferative retinopathy

Indexed keywords

ADENINE; ANGIOTENSIN RECEPTOR; CYTOSINE;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY CELL; MAJOR CLINICAL STUDY; MALE; MICROANGIOGRAPHY; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RECEPTOR GENE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0029895507     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.6.1019     Document Type: Article

References (43)

1. Parving H-H, Østerby R, Anderson PW, Hsueh WA. Diabetic nephropathy, In: Brenner BM, ed. The Kidney. Saunders, Philadelphia: 1996: 1864-1892
2. Wilson DM, Luetscher JA. Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med 1990; 323: 1101-1106
3. Franken AAM, Derkx FHM, Man in't Veld AJ et al. High plasma prorenin in diabetes mellitus and its correlation with some complications. J Clin Endocrinol 1990; 71: 1008-1015
4. Lieberman J, Sastre A. Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Ann Intern Med 1980; 93: 825-826
5. van Dyk J, Erman A, Erman F, Chen-Gal B, Sulkes J, Boner G. Increased serum angiotensin converting enzyme activity in type I insulin-dependent diabetes mellitus: its relation to metabolic control and diabetic complications. Eur J Clin Invest 1994; 24: 463-467
6. Whitebread S, Mele M, Kamber B, DeGasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989; 163: 284-291
7. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M. Characterization of angiotensin II receptor subtypes in rat heart. Circ Res 1992; 71: 1482-1489
8. Sechi LA, Grady EF, Griffin CA, Kalinyak JE, Schambelan M. Distribution of angiotensin II receptor subtypes in rat and human kidney. Am J Physiol 1992; 262: F236-F240
9. Furuta H, Guo D-F, Inagami T. Molecular cloning and sequencing of the gene encoding human angiotensin II type 1 receptor. Biochem Biophys Res Commun 1992; 183: 8-13
10. Takayanagi R, Ohnaka K, Sakai Y et al. Molecular cloning, sequence analysis and expression of a cDNA encoding human type-1 angiotensin II receptor. Biochem Biophvs Res Commun 1992; 183: 910-916
11. Bonnardeaux A, Davies E, Jeunemaitre X et al. Angiotensin II type 1 receptor gene polymorphism in human essential hypertension. Hypertension 1994; 24: 63-69
12. Krolewski AS, Canessa H, Warram JH et al. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988; 318: 140-145
13. Mangili R, Bending JJ, Scott GS, Lai LK, Gupta A, Viberti GC. Increased sodium-lithium counter transport activity in red cells of patients with insulin dependent diabetes and nephropathy. N Engl J Med 1988; 318: 146-150
14. Danser AHJ, van den Dorpel MA, Deinum J et al. Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J Clin Endocrinol Metab 1989; 68: 160-167
15. Tarnow L, Cambien F, Rossing P et al. Lack of relationship between an insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995; 44: 489-494
16. Tarnow L, Cambien F, Rossing P et al. Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 1995; 38: 798-803
17. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press, New York, Plainview: 1991
18. Feldt-Rasmussen B, Dinesen B, Deckert M. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 1985; 45: 539-544
19. Tiret L, Bonnardeaux A, Poirier O et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994; 344: 910-913
20. Parving H-H. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus. Diabetes Care 1991; 14: 260-269
21. Rossing P, Hommel E, Smidt UM, Parving H-H. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 1993; 42: 715-719
22. Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982; 72: 375-380
23. Earle K, Walker J, Hill C, Viberti GC. Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1992; 326: 673-677
24. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease: Evidence of genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320: 1161-1165
25. Borch-Johnsen K, Nørgaard K, Hommel E et al. Is diabetic nephropathy an inherited complication? Kidney Int 1992; 41: 719-722
26. Anderson PW, Do YS, Hsueh WA. Angiotensin II causes mesangial cell hypertrophy. Hypertension 1993; 21: 29-35
27. Wolf G, Haberstroh U, Neilson EG. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathology 1992; 140: 95-107
28. Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC. Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984; 74: 1143-1155
29. Steffes MW, Bilous RW, Sutherland DER, Mauer SM. Cell and matrix components of the glomerular mesangium in type 1 diabetes. Diabetes 1992; 41: 679-684
30. Chiu AT, Herblin WF, Ardecky RJ et al. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989; 165: 196-203
31. Marre M, Bernadet P, Gallois Y et al. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994; 43: 384-388
32. Doria A, Warram JH, Krolewski AS. Genetic predisposition to diabetic nephropathy. Evidence for a role of the Angiotensin I-converting enzyme gene. Diabetes 1994; 43: 690-695
33. Anderson S, Rennke HG, Garcia DL, Brenner BM. Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 1989; 36: 526-536
34. Anderson S, Rennke HG, Brenner BM. Nifedipine versus fosinopril in uninephrectomized diabetic rats. Kidney Int 1992; 41: 891-897
35. Marre M, Chatellier G, Leblanc H, Guyenne T-T, Ménard J, Passa Ph. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 1988; 297: 1092-1095
36. Mathiesen ER, Hommel E, Giese J, Parving H-H. Efficacy of captopril in postponing nephropathy in normotensive diabetic patients with microalbuminuria. Br Med J 1991; 303: 81-87
37. Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M. Beneficial effect of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 1986; 293: 471-474
38. Lewis E, Hunsicker L, Bain R, Rhode R. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462
39. Schmidt S, Schöne N, Ritz E, The Diabetic Nephropathy Study Group. Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 1995; 47: 1176-1181
40. Caulfield M, Lavender P, Farrell M et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330: 1629-1633
41. Tarnow L, Cambien F, Rossing P et al. Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 1996;
42. Fernandez LA, Twickler J, Mead A. Neovascularization produced by angiotensin II. J Lab Clin Med 1985; 105: 141-145
43. Christlieb AR, Janka H-U, Kraus B et al. Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects. Diabetes 1976; 25: 268-274